SCHEMBL4002997

SCHEMBL4002997

O=C1[N]C2(CCN(C(=O)c3cccc(F)c3F)CC2)NC1Cc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 5/20 0.47
CYP2C19 P33261 5/20 0.47
MAPK14 Q16539 5/20 0.47
HPGD P15428 1/20 0.46
HTR2B P41595 3/20 0.39
AVPR1A P37288 1/20 0.39
GRM5 P41594 1/20 0.38
HTT P42858 3/20 0.38
KDM4E B2RXH2 2/20 0.38
ALDH1A1 P00352 2/20 0.38
TSHR P16473 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
ATM Q13315 1/20 0.38
PKM P14618 1/20 0.37
NOS1 P29475 1/20 0.36
NOS2 P35228 1/20 0.36
PARP1 P09874 1/20 0.36
HCRTR1 O43613 1/20 0.36
HCRTR2 O43614 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4003459 0.93 CYP2C9 (0.56) CYP2C9CYP2C19MAPK14HTR2BHTT
SCHEMBL5670552 0.85 AVPR1A (0.56) AVPR1AKDM4EALDH1A1
SCHEMBL1800228 0.81 CYP2C9 (0.46) CYP2C9CYP2C19MAPK14HPGDHTR2B
SCHEMBL5668948 0.81 CYP2C19 (0.46) CYP2C9CYP2C19MAPK14HTR2BALDH1A1
Hydrochloric Acid SCHEMBL1802301 0.80 CYP2C9 (0.45) CYP2C9CYP2C19MAPK14HPGDHTR2B
SCHEMBL2941843 0.80 CYP2C9 (0.45) CYP2C9CYP2C19MAPK14HPGDHTR2B
SCHEMBL3997310 0.80 CHRNA4 (0.41) CYP2C9CYP2C19MAPK14ALDH1A1TSHR
SCHEMBL3999620 0.80 MAPK1 (0.46) CYP2C19HPGDHTR2BALDH1A1TSHR
SCHEMBL5666405 0.78 CYP3A4 (0.58) CYP2C19HPGDALDH1A1SMN1; SMN2
SCHEMBL5668375 0.78 MEN1 (0.45) ALDH1A1TSHRSMN1; SMN2PARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005095402-A9 SUBSTITUTED 1,4,8-TRIAZASPIRO[4.5]DECAN-2-ON COMPOUNDS FOR USE IN THE TREATMENT OF OBESITY GRUENENTHAL GMBH (DE) 2009-06-11 WO claimed
EP-1730147-A1 SUBSTITUTED 1,4,8-TRIAZASPIRO[4,5]DECAN-2-ON COMPOUNDS FOR USE IN THE TREATMENT OF OBESITY Grünenthal GmbH (DE) 2006-12-13 EP claimed
WO-2005095402-A1 SUBSTITUTED 1,4,8-TRIAZASPIRO[4.5]DECAN-2-ON COMPOUNDS FOR USE IN THE TREATMENT OF OBESITY Grünenthal GmbH (DE) 2005-10-13 WO claimed
WO-2005095402-A9 SUBSTITUTED 1,4,8-TRIAZASPIRO[4.5]DECAN-2-ON COMPOUNDS FOR USE IN THE TREATMENT OF OBESITY GRUENENTHAL GMBH (DE) 2009-06-11 WO disclosed